{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:14:00Z","timestamp":1789431240641,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"DOI":"10.7759\/cureus.98954","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:09:06Z","timestamp":1765451346000},"source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Hyperpigmentation After Sclerotherapy Through Mesotherapy With Deferoxamine Mesylate: A Case Series"],"prefix":"10.7759","author":[{"given":"Brenno Augusto S","family":"Mello Netto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Zeilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilmar S","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Marcelo","family":"Corassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins","author":"Goldman MP","year":"2007","unstructured":"Goldman MP, Bergan JJ, Guex JJ. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. Mosby Elsevier, 2007."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01409.x","article-title":"Complications of sclerotherapy: an update","volume":"36 Suppl 2","author":"Guex JJ","year":"2010","unstructured":"Guex JJ. Complications of sclerotherapy: an update. Dermatol Surg. 2010, 36 Suppl 2:1056-63. 10.1111\/j.1524-4725.2009.01409.x","journal-title":"Dermatol Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/02683555251357095","article-title":"Revealing the origin of postsclerotherapy hyperpigmentation: identification of melanin and hemosiderin as causative pigments in a histopathological study","author":"Bossart S","year":"2025","unstructured":"Bossart S, Ramelet AA, Seyed Jafari SM, et al.. Revealing the origin of postsclerotherapy hyperpigmentation: identification of melanin and hemosiderin as causative pigments in a histopathological study. Phlebology. 2025, 2683555251357095. 10.1177\/02683555251357095","journal-title":"Phlebology"},{"key":"ref4","article-title":"Postinflammatory hyperpigmentation: a review of epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis EC","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010, 3:20-31.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12849","article-title":"Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal","volume":"44","author":"Park JY","year":"2017","unstructured":"Park JY, Park JH, Kim SJ, et al.. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017, 44:118-24. 10.1111\/cup.12849","journal-title":"J Cutan Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2020.06.019","article-title":"Reducing hyperpigmentation after sclerotherapy: a randomized clinical trial","volume":"9","author":"Gonzalez Ochoa AJ","year":"2021","unstructured":"Gonzalez Ochoa AJ, Carrillo J, Manr\u00edquez D, et al.. Reducing hyperpigmentation after sclerotherapy: a randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2021, 9:154-62. 10.1016\/j.jvsv.2020.06.019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2007.00321.x","article-title":"Hyperpigmentation and melasma","volume":"6","author":"Rigopoulos D","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol. 2007, 6:195-202. 10.1111\/j.1473-2165.2007.00321.x","journal-title":"J Cosmet Dermatol"},{"key":"ref8","article-title":"Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate","volume":"27","author":"Lopez L","year":"2001","unstructured":"Lopez L, Dilley RB, Henriquez JA. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate. Dermatol Surg. 2001, 27:795-798.","journal-title":"Dermatol Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2025.102285","article-title":"Pigmentation after foam or cryo-laser cryo-sclerotherapy for lower limb reticular veins: a within-patient randomized trial","volume":"13","author":"Rodrigues A","year":"2025","unstructured":"Rodrigues A, Puggina J, da Silva VS, et al.. Pigmentation after foam or cryo-laser cryo-sclerotherapy for lower limb reticular veins: a within-patient randomized trial. J Vasc Surg Venous Lymphat Disord. 2025, 13:102285. 10.1016\/j.jvsv.2025.102285","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref10","article-title":"Avalia\u00e7\u00e3o pr\u00e9-cl\u00ednica dos efeitos profil\u00e1ticos do extrato de Pinus pinaster (Pycnogenol\u00ae) sobre a deposi\u00e7\u00e3o cut\u00e2nea de hemossiderina","volume":"11 (1)","author":"Mello Netto BAS","year":"2019","unstructured":"Mello Netto BAS, Corassa JM, Facchini G, et al.. Avalia\u00e7\u00e3o pr\u00e9-cl\u00ednica dos efeitos profil\u00e1ticos do extrato de Pinus pinaster (Pycnogenol\u00ae) sobre a deposi\u00e7\u00e3o cut\u00e2nea de hemossiderina. Surg Cosmet Dermatol. 2019, 11 (1):21-25.","journal-title":"Surg Cosmet Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425533-treatment-of-hyperpigmentation-after-sclerotherapy-through-mesotherapy-with-deferoxamine-mesylate-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:09:07Z","timestamp":1765451347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425533-treatment-of-hyperpigmentation-after-sclerotherapy-through-mesotherapy-with-deferoxamine-mesylate-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.98954","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}